An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation.

Salman Rafi  Punekar

Research Funding - Astellas Pharma (Inst); Constellation Pharmaceuticals (Inst); NCI (Inst); Prelude Therapeutics (Inst); Revolution Medicines (Inst); Simcere (Inst); Tango Therapeutics (Inst); VITRAC Therapeutics (Inst)

Meredith  Pelster

Honoraria - Castle Biosciences (I)

Consulting or Advisory Role - Arcus Biosciences (Inst); AstraZeneca (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Elevation Oncology (Inst); EMD Serono (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst)

Research Funding - 1200 Pharma (Inst); Actuate Therapeutics (Inst); Agenus (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BeiGene (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Codiak Biosciences (Inst); Compass Therapeutics (Inst); CytomX Therapeutics (Inst); Eisai (Inst); Elevation Oncology (Inst); Exelixis (Inst); Gilead Sciences (Inst); HiberCell (Inst); Immune-Onc Therapeutics (Inst); IMPAC Medical Systems (Inst); Leap Therapeutics (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Panbela Therapeutics (Inst); Revolution Medicines (Inst); SQZ Biotechnology (Inst); Surface Oncology (Inst); Tachyon Therapeutics (Inst); Translational Genomics Research Institute (Inst); TransThera Sciences (Nanjing), Inc. (Inst); ZielBio (Inst)

Carlos Roberto  Becerra

Consulting or Advisory Role - Ipsen; Legend Biotech

J. Randolph  Hecht

Stock and Other Ownership Interests  - Actym Therapeutics; Rafael Pharmaceuticals

Consulting or Advisory Role - Astellas Pharma; Corcept Therapeutics; Exelixis; Gilead Sciences; Istari; Notch Therapeutics; Regenacy Pharmaceuticals; Tempus

Research Funding - A2 Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); Bold Therapeutics (Inst); Camurus (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Lilly (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Tesaro/GSK (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst)

Travel, Accommodations, Expenses - Amgen

Andrew Scott  Paulson

Employment - Day One Biopharmaceuticals (I)

Stock and Other Ownership Interests  - Actinium Pharmaceuticals

Honoraria - Array BioPharma; Cardinal Health; Curio Science

Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Amgen; Array BioPharma; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; Eisai; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Hutchison MediPharma; Incyte; Ipsen; Jazz Pharmaceuticals; Lilly; Mirati Therapeutics; Novartis; Pfizer; QED Therapeutics; Seagen; SERVIER; Stromatis Pharma; Takeda

Speakers' Bureau - Ideo Oncology

Research Funding - AstraZeneca (Inst); Bayer (Inst); BioNTech SE (Inst); bristol myers squibb (Inst); Buzzard Pharmaceuticals; Camurus (Inst); Camurus (Inst); Deciphera (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); incyte (Inst); Innovative Cellular Therapeutics Co (Inst); Inspirna (Inst); Ipsen (Inst); ITM Oncologics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Regenxbio (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst); Tempus (Inst); TransThera Biosciences (Inst); Zentalis (Inst)

Travel, Accommodations, Expenses - AADi; Camurus; Mirati Therapeutics; Nucana; Pfizer

Patrick  Grierson

Employment - Walgreens (I)

Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer

Maria Pia  Morelli

No Relationships to Disclose

Rom  Leidner

Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CDR-Life; Merck; VIR Biotechnology

Research Funding - AstraZeneca; Bristol-Myers Squibb; Incyte

Travel, Accommodations, Expenses - Bristol-Myers Squibb

Mandana  Kamgar

Research Funding - Cornerstone Pharmaceuticals (Inst); OneCell Diagnostics India (Inst)

Joaquina Celebre  Baranda

Stock and Other Ownership Interests  - Aprea Therapeutics; Merus NV; Moderna Therapeutics; Zymeworks

Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)

Syed Mohammad Ali  Kazmi

Stock and Other Ownership Interests  - Johnson & Johnson/Janssen

Ardaman  Shergill

Honoraria - ASCO; Cholangiocarcinoma Foundation; cholangiocarcinoma summit; Colon Cancer Alliance; Curio Science; oklahoma society of clinical oncology; OncLive/MJH Life Sciences; saint joseph hospital Chicago

Consulting or Advisory Role - Catalyst Pharmaceuticals; Guardant Health; KLJ Associates; Pfizer; Pfizer; Triptych Health Partners

Research Funding - Astellas Pharma (Inst); BMS (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Gossamer Bio (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); Macrogenics (Inst); Merck (Inst); Oncologie (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); TP Therapeutics (Inst); verastem (Inst)

Travel, Accommodations, Expenses - colon cancer alliance; Takeda

Anne M.  Robinson

Employment - Artiva

Stock and Other Ownership Interests  - Artiva

Consulting or Advisory Role - Artiva

Travel, Accommodations, Expenses - Artiva; Artiva

Anuradha  Patel

Employment - Neogene Therapeutics

Ying  Yan

Employment - Neogene Therapeutics, Inc. – An AstraZeneca Group company; Sorrento Therapeutics

Stock and Other Ownership Interests  - Sorrento Therapeutics

Travel, Accommodations, Expenses - Neogene Therapeutics, Inc. – An AstraZeneca Group company; Sorrento Therapeutics

Jeroen  van Heijst

Employment - Neogene Therapeutics

Stock and Other Ownership Interests  - Neogene Therapeutics

Nathan  Demars

No Relationships to Disclose

Arianne  Perez

Employment - Neogene Therapeutics

Leadership - Neogene Therapeutics

Stock and Other Ownership Interests  - Allogene Therapeutics; Cellectis; Century Therapeutics; Kite, a Gilead company; Neogene Therapeutics

Patents, Royalties, Other Intellectual Property - Patents resulting from work at Kite Pharma and Kite, a Gilead company

Travel, Accommodations, Expenses - Neogene Therapeutics

Sarah  Cohen

Employment - Crispr Therapeutics; Neogene Therapeutics

Stock and Other Ownership Interests  - Crispr Therapeutics; Neogene Therapeutics

Patents, Royalties, Other Intellectual Property - Crispr Therapeutics

Travel, Accommodations, Expenses - Crispr Therapeutics; Neogene Therapeutics

Marwan  Fakih

Honoraria - Amgen

Consulting or Advisory Role - Bayer; BMS; Eisai; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Taiho Pharmaceutical

Research Funding - Agenus (Inst); Roche/Genentech (Inst); Verastem (Inst)